Association between routine blood biomarkers, lung phenotypes and disease severity in patients with alpha-1 antitrypsin Pi*SZ deficiency from the EARCO Registry - Vienna 2024

Novelties in alpha-1 antitrypsin deficiency

Chair(s): Ilaria Ferrarotti, Augusta Beech

Session type: Poster session

Association between routine blood biomarkers, lung phenotypes and disease severity in patients with alpha-1 antitrypsin Pi*SZ deficiency from the EARCO Registry

Cristina Aljama Vizcarra

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Systematic literature review of pulmonary function decline in AATD-associated liver/lung disease

Alice Turner

Poster

Abstract

Blood neutrophil transcriptome in PiMM and PiZZ patients with chronic obstructive pulmonary disease (COPD)

Urszula Lechowicz

Poster

Abstract

Polymer Formation in Patients with Alpha-1-Antitrypsin Deficiency, Comparison of Pi*ZZ, SZ and other Rare Allele Variants

Arturo Olivares Rivera

Poster

Abstract

Unraveling the past: A review of patients with Alpha-1 Antitrypsin Deficiency

Maria Jo?o Gomes Moura

Poster

Abstract

An inverse association between plasma levels of ?2-macroglobulin and ?1- antitrypsin in COPD patients

Sabina Janciauskiene Wallmark

Poster

Abstract

Analysis of emphysema severity and emphysema characteristics using quantitative computed tomography in patients with alpha-1 antitrypsin deficiency

Philipp H?ger

Poster

Abstract

Hepatic features in patients with severe alpha1-antitrypsin deficiency: a single institution experience

Xheni Veselagu

Poster

Abstract

Clinical and radiological clustering in patients with alpha1-antitrypsin deficiency caused by PI*SZ genotype

Ilaria Giana

Poster

Abstract

Liver disease in patients with alpha1 antitrypsin deficiency PiZZ and PiSZ from the Spanish EARCO registry.

Cristina Aljama Vizcarra

Poster

Abstract

Non-targeted screening for Alpha-1 Antitrypsin Deficiency

Thomas K?hnlein

Poster

Abstract

Impact and prevalence of alpha-1 antitrypsin deficiency in different lung diseases

N?ria Angrill Sell

Poster

Abstract

The final results of European external quality control program for laboratory testing of alpha1-antitrypsin deficiency (AATD EARCO LABNet) 2019-2022

Magdalena Pelc

Poster

Abstract

Proteinase 3 (PR3) specific fibrinopeptide A?-Val541 in alpha-1 antitrypsin deficiency (AATD) patients receiving a liver transplantation

Emily F. A. Van 't Wout

Poster

Abstract

The alpha-1 foundation research registry: smoking history and obstructive lung disease in alpha-1 antitrypsin deficiency patients in the united states

Alison Keaveny

Poster

Abstract

Rapid DNA extraction methods to facilitate laboratory workflow in Alpha-1 Antitrypsin Deficiency detection

Amaia Larruskain

Poster

Abstract

Heterozygous Alpha-1 Antitrypsin Deficiency in COPD patients

Martina Zappa

Poster

Abstract

Alpha 1 Antitrypsin deficiency associated with the Mmalton variant: an EARCO Research project.

Maria Beatriz Dias Ferraz

Poster

Abstract

SERPINA1 Q0Q0 clinical presentation of a very rare alpha-1 antitrypsin deficiency

Effrosyni D. Manali

Poster

Abstract

Association between routine blood biomarkers, lung phenotypes and disease severity in patients with alpha-1 antitrypsin Pi*SZ deficiency from the EARCO Registry

Cristina Aljama Vizcarra

Poster

Abstract

Lung disease in never smokers with severe alpha1-antitrypsin deficiency: The EARCO Registry.

Chiara Premuda

Poster

Abstract

CDN Connection Issue

The ERS Congress 2024, Vienna

#{title}